BCAL Diagnostics (ASX:BDX) Accounts Payable : A$0.77 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Accounts Payable?

BCAL Diagnostics's Accounts Payable for the quarter that ended in Dec. 2023 was A$0.77 Mil.

BCAL Diagnostics's quarterly Accounts Payable increased from Dec. 2022 (A$0.34 Mil) to Jun. 2023 (A$1.58 Mil) but then declined from Jun. 2023 (A$1.58 Mil) to Dec. 2023 (A$0.77 Mil).

BCAL Diagnostics's annual Accounts Payable increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.28 Mil) and increased from Jun. 2022 (A$0.28 Mil) to Jun. 2023 (A$1.58 Mil).

BCAL Diagnostics Accounts Payable Historical Data

The historical data trend for BCAL Diagnostics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Accounts Payable Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Accounts Payable

0.28

1.58

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial			0.30	0.28	0.34	1.58	0.77

BCAL Diagnostics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

BCAL Diagnostics Accounts Payable Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.